−0.1015USD
−3.50 MUSD
11.10 KUSD
28.57 M
About Quantum Genomics
Sector
CEO
Jean-Philippe Milon
Headquarters
Paris
Website
Founded
2005
ISIN
FR0011648971
FIGI
BBG00H1CB0S1
Quantum Genomics SA is a biopharmaceutical company, which engages in the development of therapies for cardiovascular diseases. It focuses on the development of drug class based on the central action mechanism of Aminopeptidase A inhibition. The company was founded by Lionel Ségard on December 23, 2005 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of QNNTF is 0.1010 USD — it has decreased by 97.03% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Quantum Genomics stocks are traded under the ticker QNNTF.
Quantum Genomics is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
QNNTF stock is 3.27 K% volatile and has beta coefficient of 0.83. Check out the list of the most volatile stocks — is Quantum Genomics there?
Yes, you can track Quantum Genomics financials in yearly and quarterly reports right on TradingView.
QNNTF stock hasn't changed in a week, the last month showed zero change in price, over the last year Quantum Genomics has showed a 97.03% decrease.
QNNTF net income for the last quarter is −1.31 M USD, while the quarter before that showed −2.17 M USD of net income which accounts for 39.59% change. Track more Quantum Genomics financial stats to get the full picture.
Today Quantum Genomics has the market capitalization of 4.22 M, it has decreased by 3.05% over the last week.
No, QNNTF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, QNNTF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Quantum Genomics stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Quantum Genomics EBITDA is −3.47 M USD, and current EBITDA margin is −31.26 K%. See more stats in Quantum Genomics financial statements.